Financial Performance - Q1 2025 revenues reached $9.3 million, marking a 61% increase from $5.8 million in Q1 2024, representing the highest quarterly revenues in the company's history [1][5] - Gross margin for Q1 2025 was 79.0%, up from 72.6% in Q1 2024 [1][5] - GAAP Operating Income for Q1 2025 was $1.0 million, an increase of $2.0 million compared to Q1 2024 [1][5] - The company reported a net loss of $5.7 million in Q1 2025, compared to a net loss of $4.5 million in Q1 2024 [5][21] Sales and Market Activity - The company sold 98 UltraMist® systems in Q1 2025, which is 128% more than the 43 systems sold in the same quarter last year [3][5] - UltraMist® consumables revenue increased by 43% to $5.8 million in Q1 2025, accounting for 99% of the company's overall revenues [5][21] Future Guidance - The company provides guidance for Q2 2025 revenue growth of 40-50% compared to Q2 2024, estimating revenues between $10.0 million and $10.7 million [4][5] - Full year 2025 revenue guidance is reiterated at $48-50 million, indicating a 47-53% increase compared to full year 2024 revenue [4][5] Operational Strategy - The company is focused on expanding its commercial operations and clinical teams to support ongoing growth while enhancing profitability [3] - The company has achieved comfortable inventory levels for both systems and applicators, allowing for aggressive engagement with larger customers [3]
Sanuwave Announces Q1 FY2025 Financial Results